Poly(ADP-Ribose) Polymerase Inhibition Reduces Reperfusion Injury After Heart Transplantation
暂无分享,去创建一个
S. Hagl | C. Vahl | T. Csont | É. Szabó | C. Szabó | L. Liaudet | R. Schulz | T. Dengler | P. Pacher | G. Southan | P. Jagtap | G. Szabó | S. Bährle | N. Stumpf | K. Sonnenberg
[1] F. Althaus,et al. ADP-ribosylation of proteins. Enzymology and biological significance. , 2012, Molecular biology, biochemistry, and biophysics.
[2] C. Szabó,et al. Myocardial Ischemic Preconditioning in Rodents Is Dependent on Poly (ADP-Ribose) Synthetase , 2001, Molecular medicine.
[3] M. Endres,et al. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. , 2001, International journal of molecular medicine.
[4] C. Szab,et al. Poly(ADP-ribose) polymerase activation and the pathogenesis of circulatory shock , 2000 .
[5] C. Thiemermann,et al. An inhibitor of poly (ADP‐ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischaemic rat heart , 1999, British journal of pharmacology.
[6] C. Vahl,et al. Endothelin-A and -B antagonists protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model. , 1998, Cardiovascular Research.
[7] S. Hagl,et al. l-Arginine: Effect on Reperfusion Injury after Heart Transplantation , 1998, World Journal of Surgery.
[8] B. Zingarelli,et al. Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. , 1998, Circulation research.
[9] S. Cuzzocrea,et al. Peroxynitrite‐induced thymocyte apoptosis: the role of caspases and poly (ADP‐ribose) synthetase (PARS) activation , 1998, Immunology.
[10] V. Dawson,et al. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. , 1998, Trends in pharmacological sciences.
[11] C. Le Page,et al. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. , 1998, Biochemical and biophysical research communications.
[12] S. Cuzzocrea,et al. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. , 1997, Cardiovascular research.
[13] S. Cuzzocrea,et al. Inhibition of poly (ADP-ribose) Synthetase Attenuates Neutrophil Recruitment and Exerts Antiinflammatory Effects , 1997, The Journal of experimental medicine.
[14] S. Cuzzocrea,et al. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. , 1997, The Journal of clinical investigation.
[15] S. Cuzzocrea,et al. Beneficial effects of 3‐aminobenzamide, an inhibitor of poly (ADP‐ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion , 1997, British journal of pharmacology.
[16] R. Roeder,et al. Poly(ADP-ribose) polymerase enhances activator-dependent transcription in vitro. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[17] G. Buckberg,et al. Endothelial stunning and myocyte recovery after reperfusion of jeopardized muscle: a role of L-arginine blood cardioplegia. , 1997, The Journal of thoracic and cardiovascular surgery.
[18] C. Thiemermann,et al. Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[19] B. Zingarelli,et al. Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. , 1996, Circulation research.
[20] M. O’connor,et al. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Galiñanes,et al. Effects of cardioplegia on vascular function and the "no-reflow" phenomenon after ischemia and reperfusion: studies in the isolated blood-perfused rat heart. , 1996, The Journal of thoracic and cardiovascular surgery.
[22] H. Kolb,et al. Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells , 1995, The Journal of Biological Chemistry.
[23] C. Smith,et al. P-selectin and ICAM-1-dependent adherence reactions: role in the genesis of postischemic no-reflow. , 1994, The American journal of physiology.
[24] M. Komatsu,et al. ATP-sensitive K+ channel-independent glucose action in rat pancreatic beta-cell. , 1994, The American journal of physiology.
[25] A. M. Lefer,et al. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. , 1993, The Journal of clinical investigation.
[26] L. Cohn,et al. Improved recovery of heart transplants by combined use of oxygen-derived free radical scavengers and energy enhancement. , 1992, The Journal of thoracic and cardiovascular surgery.
[27] M. Galiñanes,et al. Exogenous adenosine accelerates recovery of cardiac function and improves coronary flow after long-term hypothermic storage and transplantation. , 1992, The Journal of thoracic and cardiovascular surgery.
[28] R. Thies,et al. Reactive oxygen injury to cultured pulmonary artery endothelial cells: mediation by poly(ADP-ribose) polymerase activation causing NAD depletion and altered energy balance. , 1991, Archives of biochemistry and biophysics.
[29] D. Hinshaw,et al. Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. , 1986, The Journal of clinical investigation.
[30] S. J. Berger,et al. Poly(ADP-ribose) Polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5'-triphosphate pools in DNA-damaged cells: mechanism of stimulation of unscheduled DNA synthesis. , 1983, Biochemistry.
[31] H. Kröger,et al. Inhibition of the induction of collagenase by interleukin-1 β in cultured rabbit synovial fibroblasts after treatment with the poly(ADP-ribose)-polymerase inhibitor 3-aminobenzamide , 2004, Rheumatology International.
[32] K. Murthy,et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation , 2001, Nature Medicine.
[33] C. Thiemermann,et al. Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress. , 1999, Cardiovascular research.
[34] G. Grupp,et al. Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts. , 1999, Journal of molecular and cellular cardiology.
[35] K. Roebuck,et al. H2O2 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. , 1995, The Journal of biological chemistry.
[36] M. Galiñanes,et al. Metabolic, functional, and histologic characterization of the heterotopically transplanted rat heart when used as a model for the study of long-term recovery from global ischemia. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[37] J. Jackson,et al. Oxidant injury of cells. , 1987, International journal of tissue reactions.